Apyx Medical Stock Last Dividend Paid

APYX Stock

USD 1.57 0.05 3.29%

Apyx Medical fundamentals help investors to digest information that contributes to Apyx Medical's financial success or failures. It also enables traders to predict the movement of Apyx Stock. The fundamental analysis module provides a way to measure Apyx Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Apyx Medical stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Apyx Medical Company Last Dividend Paid Analysis

Apyx Medical's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.

Last Dividend

Last Profit Distribution Amount

Total Shares

More About Last Dividend Paid | All Equity Analysis

Apyx Last Dividend Paid Driver Correlations

Understanding the fundamental principles of building solid financial models for Apyx Medical is extremely important. It helps to project a fair market value of Apyx Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since Apyx Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Apyx Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Apyx Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.71	0.05	-0.48	-0.01	0.74	0.71	-0.44	0.62	1.0	0.52	-0.74	-0.04	0.32	0.71	0.82	-0.59	0.74	-0.7	-0.88	0.88	0.95	0.53
Total Stockholder Equity	0.71		0.43	-0.76	0.61	0.22	0.41	-0.3	-0.11	0.72	0.67	-0.54	0.05	0.24	0.28	0.95	-0.55	0.46	-0.56	-0.71	0.87	0.77	-0.09
Current Deferred Revenue	0.05	0.43		-0.52	0.4	-0.12	-0.09	-0.24	-0.41	0.07	0.18	0.08	-0.06	0.15	-0.18	0.26	0.12	0.05	0.01	0.01	0.21	0.07	-0.45
Net Debt	-0.48	-0.76	-0.52		-0.48	-0.22	-0.4	0.18	0.17	-0.5	-0.6	0.46	-0.14	-0.16	-0.42	-0.71	0.37	-0.36	0.42	0.55	-0.63	-0.52	0.21
Retained Earnings	-0.01	0.61	0.4	-0.48		-0.57	-0.36	0.09	-0.7	0.01	0.26	0.06	0.04	-0.13	-0.43	0.49	-0.04	-0.38	0.04	0.02	0.35	0.15	-0.58
Accounts Payable	0.74	0.22	-0.12	-0.22	-0.57		0.83	-0.34	0.8	0.74	0.33	-0.68	0.05	0.24	0.88	0.37	-0.44	0.82	-0.6	-0.74	0.45	0.61	0.7
Net Receivables	0.71	0.41	-0.09	-0.4	-0.36	0.83		-0.31	0.55	0.71	0.61	-0.75	0.11	0.27	0.89	0.51	-0.58	0.84	-0.68	-0.83	0.52	0.61	0.48
Good Will	-0.44	-0.3	-0.24	0.18	0.09	-0.34	-0.31		-0.27	-0.38	-0.24	-0.12	0.77	-0.72	-0.31	-0.17	0.05	-0.19	0.13	0.17	-0.17	-0.2	-0.06
Total Liab	0.62	-0.11	-0.41	0.17	-0.7	0.8	0.55	-0.27		0.6	-0.01	-0.45	-0.1	0.21	0.69	0.09	-0.21	0.55	-0.38	-0.47	0.28	0.5	0.85
Total Current Assets	1.0	0.72	0.07	-0.5	0.01	0.74	0.71	-0.38	0.6		0.53	-0.78	0.04	0.25	0.7	0.84	-0.61	0.75	-0.71	-0.89	0.9	0.97	0.51
Short Term Debt	0.52	0.67	0.18	-0.6	0.26	0.33	0.61	-0.24	-0.01	0.53		-0.51	0.07	0.25	0.48	0.65	-0.49	0.48	-0.54	-0.66	0.61	0.54	-0.03
Intangible Assets	-0.74	-0.54	0.08	0.46	0.06	-0.68	-0.75	-0.12	-0.45	-0.78	-0.51		-0.58	0.24	-0.7	-0.74	0.64	-0.73	0.72	0.88	-0.77	-0.81	-0.4
Common Stock	-0.04	0.05	-0.06	-0.14	0.04	0.05	0.11	0.77	-0.1	0.04	0.07	-0.58		-0.81	0.01	0.24	-0.39	0.21	-0.2	-0.22	0.2	0.17	-0.03
Property Plant Equipment	0.32	0.24	0.15	-0.16	-0.13	0.24	0.27	-0.72	0.21	0.25	0.25	0.24	-0.81		0.31	0.06	0.04	0.32	-0.18	-0.21	0.1	0.13	0.19
Long Term Debt	0.71	0.28	-0.18	-0.42	-0.43	0.88	0.89	-0.31	0.69	0.7	0.48	-0.7	0.01	0.31		0.4	-0.36	0.74	-0.63	-0.78	0.49	0.6	0.57
Net Tangible Assets	0.82	0.95	0.26	-0.71	0.49	0.37	0.51	-0.17	0.09	0.84	0.65	-0.74	0.24	0.06	0.4		-0.67	0.55	-0.65	-0.82	0.95	0.89	0.1
Long Term Debt Total	-0.59	-0.55	0.12	0.37	-0.04	-0.44	-0.58	0.05	-0.21	-0.61	-0.49	0.64	-0.39	0.04	-0.36	-0.67		-0.63	0.52	0.63	-0.55	-0.58	-0.28
Capital Surpluse	0.74	0.46	0.05	-0.36	-0.38	0.82	0.84	-0.19	0.55	0.75	0.48	-0.73	0.21	0.32	0.74	0.55	-0.63		-0.71	-0.85	0.6	0.68	0.54
Deferred Long Term Liab	-0.7	-0.56	0.01	0.42	0.04	-0.6	-0.68	0.13	-0.38	-0.71	-0.54	0.72	-0.2	-0.18	-0.63	-0.65	0.52	-0.71		0.82	-0.71	-0.73	-0.35
Short Long Term Debt	-0.88	-0.71	0.01	0.55	0.02	-0.74	-0.83	0.17	-0.47	-0.89	-0.66	0.88	-0.22	-0.21	-0.78	-0.82	0.63	-0.85	0.82		-0.87	-0.9	-0.42
Net Invested Capital	0.88	0.87	0.21	-0.63	0.35	0.45	0.52	-0.17	0.28	0.9	0.61	-0.77	0.2	0.1	0.49	0.95	-0.55	0.6	-0.71	-0.87		0.96	0.19
Net Working Capital	0.95	0.77	0.07	-0.52	0.15	0.61	0.61	-0.2	0.5	0.97	0.54	-0.81	0.17	0.13	0.6	0.89	-0.58	0.68	-0.73	-0.9	0.96		0.43
Capital Stock	0.53	-0.09	-0.45	0.21	-0.58	0.7	0.48	-0.06	0.85	0.51	-0.03	-0.4	-0.03	0.19	0.57	0.1	-0.28	0.54	-0.35	-0.42	0.19	0.43

Click cells to compare fundamentals

Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.

Competition

Predict Apyx Medical

Apyx Dividend Paid And Capex Coverage Ratio

Dividend Paid And Capex Coverage Ratio

(11.89)

At this time, Apyx Medical's Dividend Paid And Capex Coverage Ratio is fairly stable compared to the past year.

Based on the recorded statements, Apyx Medical has a Last Dividend Paid of 0.0. This indicator is about the same for the Health Care Equipment & Supplies average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Risk-Return Analysis Now

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume

All Next

Launch Module

Apyx Fundamentals

	Return On Equity	-1.1
	Return On Asset	-0.22
	Profit Margin	(0.58) %
	Operating Margin	(0.46) %
	Current Valuation	65.79 M
	Shares Outstanding	37.64 M
	Shares Owned By Insiders	16.18 %
	Shares Owned By Institutions	40.43 %
	Number Of Shares Shorted	148.57 K
	Price To Earning	4.04 X
	Price To Book	4.98 X
	Price To Sales	1.17 X
	Revenue	52.35 M
	Gross Profit	30.35 M
	EBITDA	(18.11 M)
	Net Income	(18.85 M)
	Cash And Equivalents	20.06 M
	Cash Per Share	0.58 X
	Total Debt	38.5 M
	Debt To Equity	0.02 %
	Current Ratio	4.45 X
	Book Value Per Share	0.77 X
	Cash Flow From Operations	(5.25 M)
	Short Ratio	5.49 X
	Earnings Per Share	(0.82) X
	Price To Earnings To Growth	(0.58) X
	Target Price	3.0
	Number Of Employees	252
	Beta	1.21
	Market Capitalization	57.22 M
	Total Asset	79.24 M
	Retained Earnings	(54.45 M)
	Working Capital	57.62 M
	Current Asset	10.01 M
	Current Liabilities	2.45 M
	Net Asset	79.24 M

About Apyx Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Apyx Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apyx Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apyx Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

EBR	Centrais Electricas Brasileiras
HE	Hawaiian Electric Industries
VFC	VF Corporation

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC